“Serum Adiponectin As a Diagnostic Marker of Early Renal Dysfunction in Patients With Hypertension and Type 2 Diabetes”. Journal of Medical Sciences, vol. 21, no. 1, June 2026, pp. 22-28, https://doi.org/10.51984/18dd9796.